Nuvation Bio Inc. Class A Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.29B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 21.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Viking Holdings Ltd Ordinary Shares is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| NUVB | VIK | |
|---|---|---|
Market Cap | $1.71B | $36.29B |
Volume | 5,448,712 | 2,522,956 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.54 | $108.26 |
52-Week Low | $3.41 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $38.67B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →